These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20585729)

  • 1. Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006.
    Aguilar-Salinas CA; Gómez-Pérez FJ; Rull J; Villalpando S; Barquera S; Rojas R
    Salud Publica Mex; 2010; 52 Suppl 1():S44-53. PubMed ID: 20585729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dyslipidemia prevalence and its relationship with insulin resistance in a population of apparently healthy subjects].
    Munguía-Miranda C; Sánchez-Barrera RG; Hernández-Saavedra D; Cruz-López M
    Salud Publica Mex; 2008; 50(5):375-82. PubMed ID: 18852934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of metabolic syndrome according to lipid alterations: analysis from the Mexican National Health and Nutrition Survey 2006.
    Pedroza-Tobias A; Trejo-Valdivia B; Sanchez-Romero LM; Barquera S
    BMC Public Health; 2014 Oct; 14():1056. PubMed ID: 25300324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population.
    Sharifi F; Mousavinasab SN; Soruri R; Saeini M; Dinmohammadi M
    Metab Syndr Relat Disord; 2008 Sep; 6(3):187-95. PubMed ID: 18774906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey.
    Aguilar-Salinas CA; Olaiz G; Valles V; Torres JM; Gómez Pérez FJ; Rull JA; Rojas R; Franco A; Sepulveda J
    J Lipid Res; 2001 Aug; 42(8):1298-307. PubMed ID: 11483632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of dyslipidemia among residents aged 18-69 years in Shandong province of China, 2011].
    Zhang J; Tang J; Guo X; Dong J; Ren J; Chen X; Gao C; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Mar; 50(3):230-4. PubMed ID: 26957240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between High Waist-to-Height Ratio and Cardiovascular Risk among Adults Sampled by the 2016 Half-Way National Health and Nutrition Survey in Mexico (ENSANUT MC 2016).
    Rangel-Baltazar E; Cuevas-Nasu L; Shamah-Levy T; Rodríguez-Ramírez S; Méndez-Gómez-Humarán I; Rivera JA
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31234359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in Mexican adults: results from the National Health and Nutrition Survey 2006.
    Rojas R; Aguilar-Salinas CA; Jiménez-Corona A; Shamah-Levy T; Rauda J; Avila-Burgos L; Villalpando S; Ponce EL
    Salud Publica Mex; 2010; 52 Suppl 1():S11-8. PubMed ID: 20585723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiological characteristics of dyslipidemia in remote rural areas of Xinjiang, 2009-2010].
    Wang YL; Yan YZ; He J; Ma JL; Zhang M; ; Zhang JY; Liu JM; Li SG; Niu Q; Rui DS; Ma RL; Guo H; Ding YS; Guo SX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Nov; 50(11):996-1000. PubMed ID: 27916084
    [No Abstract]   [Full Text] [Related]  

  • 11. Threshold-Effect Association of Dietary Cholesterol Intake with Dyslipidemia in Chinese Adults: Results from the China Health and Nutrition Survey in 2015.
    Huang Q; Jiang H; Zhang B; Wang H; Jia X; Huang F; Wang L; Wang Z
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31783560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of dyslipidemia and associated factors among the hypertensive population from rural Northeast China.
    Yu S; Yang H; Guo X; Zhang X; Zheng L; Sun Y
    BMC Public Health; 2015 Nov; 15():1152. PubMed ID: 26589291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemia prevalence, awareness, treatment and control in Mexico: results of the Ensanut 2012.
    Hernández-Alcaraz C; Aguilar-Salinas CA; Mendoza-Herrera K; Pedroza-Tobías A; Villalpando S; Shamah-Levy T; Rivera-Dommarco J; Hernández-Ávila M; Barquera S
    Salud Publica Mex; 2020; 62(2):137-146. PubMed ID: 32237556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of self-reported survey (SHIELD) versus NHANES data in estimating prevalence of dyslipidemia.
    Bays HE; Chapman RH; Fox KM; Grandy S;
    Curr Med Res Opin; 2008 Apr; 24(4):1179-86. PubMed ID: 18346311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of dyslipidemia among a rural Thai population in the Nakhon Si Thammarat province.
    Jeenduang N; Whanmasae S; Seepawin P; Kullabootr S
    J Med Assoc Thai; 2013 Aug; 96(8):992-1000. PubMed ID: 23991608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiologic characteristics of dyslipidemia in people aged 18 years and over in China].
    Zhao WH; Zhang J; You Y; Man QQ; Li H; Wang CR; Zhai Y; Li Y; Jin SG; Yang XG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Sep; 39(5):306-10. PubMed ID: 16266538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of dyslipidemias in Mexico city and Its relation to other cardiovascular risk factors. Results from the CARMELA study].
    Escobedo-de la Peña J; de Jesús-Pérez R; Schargrodsky H; Champagne B
    Gac Med Mex; 2014; 150(2):128-36. PubMed ID: 24603993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-first century epidemiology of dyslipidemia in Greece: EMENO national epidemiological study.
    Stergiou GS; Ntineri A; Menti A; Kalpourtzi N; Vlachopoulos C; Liberopoulos EN; Rallidis L; Richter D; Gavana M; Vantarakis A; Chlouverakis G; Hajichristodoulou C; Trypsianis G; Voulgari PV; Alamanos Y; Karakosta A; Touloumi G
    Hellenic J Cardiol; 2023; 69():1-8. PubMed ID: 36243397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid concentrations, prevalence of dyslipidemia, and percentage eligible for pharmacological treatment of Korean children and adolescents; data from the Korea National Health and Nutrition Examination Survey IV (2007-2009).
    Yang S; Hwang JS; Park HK; Lee HS; Kim HS; Kim EY; Lim JS
    PLoS One; 2012; 7(12):e49253. PubMed ID: 23251338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.